Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3542 studies found for:    adult stem cell transplants | Interventional Studies
Show Display Options
Rank Status Study
21 Completed
Has Results
Valaciclovir Hydrochloride Phase III for Hematopoietic Stem Cell Transplantation Patients
Condition: Herpes Simplex
Intervention: Drug: VACV tablets (Adults or pediatrics) or granules (pediatrics)
22 Active, not recruiting Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1;   Untreated Adult Acute Lymphoblastic Leukemia
Interventions: Biological: Alemtuzumab;   Procedure: Allogeneic Hematopoietic Stem Cell Transplantation;   Procedure: Autologous Hematopoietic Stem Cell Transplantation;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Dasatinib;   Drug: Daunorubicin Hydrochloride;   Drug: Dexamethasone;   Drug: Etoposide Phosphate;   Biological: Filgrastim;   Drug: Fludarabine Phosphate;   Procedure: In Vitro-Treated Peripheral Blood Stem Cell Transplantation;   Other: Laboratory Biomarker Analysis;   Drug: Leucovorin Calcium;   Drug: Melphalan;   Drug: Mercaptopurine;   Drug: Methotrexate;   Biological: Pegfilgrastim;   Other: Pharmacological Study;   Drug: Tacrolimus;   Drug: Vincristine Sulfate
23 Completed
Has Results
Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation (MK-5119-001)
Condition: Clostridium Difficile-Associated Diarrhea (CDAD)
Interventions: Drug: fidaxomicin;   Drug: Placebo
24 Completed Allogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL)
Conditions: MDS;   AML;   ALL;   BAL
Intervention: Drug: Clofarabine in combination with IV busulfan and ATG
25 Recruiting Pharmacokinetic Study of Busulfan in Allogeneic Stem Cell Transplantation in Adult Patients With Acute Leukemia
Condition: Acute Leukemia
Intervention: Drug: Busulfan
26 Recruiting Allogeneic Stem Cell Transplantation With Adoptive Immunotherapy in Epstein-Barr Virus Positive Recurrent/Refractory Hodgkins Lymphoma
Condition: Hodgkins Lymphoma
Intervention: Biological: allogeneic donor derived LMP specific cytotoxic T-lymphocyte
27 Recruiting Stem Cell Transplantation for Stiff Person Syndrome (SPS)
Condition: Stiff Person Syndrome
Intervention: Biological: Autologous Hematopoietic Stem Cell Transplantation
28 Active, not recruiting STUDY WITH LENALIDOMIDE (Revlimid®) MAINTENANCE VS OBSERVATION AFTER INTENSIFIED INDUCTION REGIMEN CONTAINING RITUXIMAB FOLLOWED BY HIGH DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION AS FIRST LINE TREATMENT IN ADULT PATIENTS WITH ADVANCED MANTLE CELL LYMPHOMA
Condition: MANTLE CELL LYMPHOMA
Intervention: Drug: Lenalidomide
29 Recruiting Safety Study of Cord Blood Units for Stem Cell Transplants
Conditions: Aplastic Anemia;   Leukemia;   Myelodysplastic Syndrome (MDS);   Lymphoma
Intervention: Procedure: Cord Blood Units
30 Active, not recruiting CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant
Conditions: Leukemia;   Lymphoma;   Bone Marrow Failure;   Immunodeficiencies;   Histiocytosis;   Sickle Cell Disease;   Beta Thalassemia;   Inborn Errors of Metabolism
Interventions: Drug: Full Intensity with TBI;   Drug: Full Intensity;   Drug: Reduced Intensity;   Drug: Reduced Intensity (Fanconi)
31 Withdrawn Busulfan Pharmacokinetic Analysis and GST Polymorphism in Adults Undergoing Hematological Stem Cell Transplantation
Conditions: Busulfan Pharmacokinetic Analysis;   GST Genetic Polymorphism
Intervention: Drug: Hematological Stem Cell Transplantation
32 Terminated Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant
Conditions: Graft Versus Host Disease;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes
Interventions: Biological: CD4+CD25+ regulatory T cells;   Procedure: allogeneic hematopoietic stem cell transplantation
33 Withdrawn Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission
Conditions: Adult Acute Erythroid Leukemia;   Adult Acute Monoblastic and Acute Monocytic Leukemia;   Adult Acute Myeloid Leukemia
Interventions: Drug: anti-thymocyte globulin;   Drug: fludarabine phosphate;   Drug: thiotepa;   Procedure: biological therapy;   Procedure: bone marrow ablation with stem cell support;   Procedure: chemotherapy;   Procedure: non-specific immune-modulator therapy;   Procedure: peripheral blood stem cell transplantation;   Procedure: radiation therapy
34 Active, not recruiting
Has Results
Rituxan + BEAM and Auto Stem Cell Transplant for High Risk Lymphoma or Hodgkin's Disease
Conditions: Lymphoma;   Hodgkin's Disease
Interventions: Drug: Melphalan;   Drug: Ara-C;   Drug: VP-16;   Drug: BCNU;   Drug: Rituxan;   Drug: Stem Cells
35 Completed
Has Results
AMD3100 (Plerixafor) With G-CSF in Poor Mobilizing Adult Patients Who Previously Failed Hematopoietic Stem Cell (HSC) Collection/Attempts
Condition: Autologous Stem Cell Transplantation
Intervention: Drug: G-CSF plus plerixafor
36 Unknown  Reduced Intensity Transplant Using Extracorporeal Photopheresis
Conditions: Leukemia;   Cancer
Intervention: Procedure: Extracorporeal Photopheresis
37 Completed Adult Double Cord Blood Transplant Study
Conditions: Cord Blood Stem Cell Transplantation;   Hematologic Malignancies
Intervention: Procedure: Cord blood transplantation
38 Withdrawn Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
Conditions: Anemia;   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Biological: filgrastim;   Drug: busulfan;   Drug: fludarabine phosphate;   Drug: methotrexate;   Drug: tacrolimus;   Procedure: allogeneic bone marrow transplantation;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation
39 Completed Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies
Conditions: Leukemia;   Acute Lymphoblastic Leukemia;   Acute Myeloid Leukemia;   Chronic Myeloid Leukemia;   Juvenile Myelomonocytic Leukemia;   Myelodysplastic Syndrome;   Paroxysmal Nocturnal Hemoglobinuria;   Hodgkin's Lymphoma;   Non-Hodgkin Lymphoma
Interventions: Drug: Systematic chemotherapy and antibodies;   Procedure: Allogeneic stem cell transplantation;   Device: Miltenyi CliniMACS
40 Unknown  Pharmacokinetic Study of Fludarabine in Pediatric Hematopoietic Stem Cell Transplantation
Conditions: Acute Leukemia;   Chronic Leukemia;   Severe Aplastic Anemia
Intervention: Drug: Fludarabine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.